Cargando…
New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies
The introduction of new targeted, biological, and cellular therapies in patients with hematologic malignancies has improved the outcomes of patients but in parallel has changed the frequency and epidemiology of infections, including invasive aspergillosis (IA). In this article, recent literature on...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662679/ https://www.ncbi.nlm.nih.gov/pubmed/31372213 http://dx.doi.org/10.12688/f1000research.17836.1 |